We only have this paper's title and publication details.
Read it at the sourceRetrospective multicenter cohort study reveals that BIRC3 mutations cause fludarabine resistance in chronic lymphocytic leukemia, highlighting a high-risk group needing targeted alternatives.
No takes yet. Share an insight, caveat, or question.
Diop et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: